Glaukos Balance Sheet Health
Financial Health criteria checks 4/6
Glaukos has a total shareholder equity of $665.2M and total debt of $56.7M, which brings its debt-to-equity ratio to 8.5%. Its total assets and total liabilities are $919.7M and $254.5M respectively.
Key information
8.5%
Debt to equity ratio
US$56.69m
Debt
| Interest coverage ratio | n/a |
| Cash | US$261.66m |
| Equity | US$665.16m |
| Total liabilities | US$254.52m |
| Total assets | US$919.68m |
Recent financial health updates
Glaukos (NYSE:GKOS) Is Carrying A Fair Bit Of Debt
Jun 11
Is Glaukos (NYSE:GKOS) A Risky Investment?
Jan 21Health Check: How Prudently Does Glaukos (NYSE:GKOS) Use Debt?
Oct 05Is Glaukos (NYSE:GKOS) Using Debt Sensibly?
Jun 28Health Check: How Prudently Does Glaukos (NYSE:GKOS) Use Debt?
Feb 19Does Glaukos (NYSE:GKOS) Have A Healthy Balance Sheet?
Oct 16Recent updates
Glaukos Corporation's (NYSE:GKOS) Intrinsic Value Is Potentially 81% Above Its Share Price
Aug 28Glaukos Corporation (NYSE:GKOS) Just Reported And Analysts Have Been Lifting Their Price Targets
Aug 07Glaukos Corporation's (NYSE:GKOS) Popularity With Investors Is Clear
Jul 18Glaukos (NYSE:GKOS) Is Carrying A Fair Bit Of Debt
Jun 11Glaukos Stock: Still Unproven Whether A New Bull Market Has Begun
May 30Here's Why Glaukos Corporation's (NYSE:GKOS) CEO Compensation Is The Least Of Shareholders' Concerns
May 24Why Glaukos Corporation (NYSE:GKOS) Could Be Worth Watching
Apr 22Glaukos Corporation (NYSE:GKOS) Not Lagging Industry On Growth Or Pricing
Apr 04Glaukos Corporation's (NYSE:GKOS) Intrinsic Value Is Potentially 69% Above Its Share Price
Feb 21Is Glaukos (NYSE:GKOS) A Risky Investment?
Jan 21Glaukos: Remains A Hold Due To High Valuation And Negative Profitability
Jan 09Glaukos Corporation's (NYSE:GKOS) 27% Jump Shows Its Popularity With Investors
Dec 20Why Glaukos Corporation (NYSE:GKOS) Could Be Worth Watching
Nov 03Health Check: How Prudently Does Glaukos (NYSE:GKOS) Use Debt?
Oct 05Glaukos: Continued Growth Rates, Regulatory Tailwinds, And Support
Sep 01Is Glaukos (NYSE:GKOS) Using Debt Sensibly?
Jun 28Glaukos: Revising To Buy On These 3 Catalytic Factors
Jun 16Risks To Shareholder Returns Are Elevated At These Prices For Glaukos Corporation (NYSE:GKOS)
Apr 19Health Check: How Prudently Does Glaukos (NYSE:GKOS) Use Debt?
Feb 19Glaukos: Trial Momentum Building, Profitability Differentials Yet To Pull Through
Feb 14Glaukos sees positive data from mid-stage trial of dry eye treatment
Jan 10Glaukos: Show Me The Money
Nov 10Does Glaukos (NYSE:GKOS) Have A Healthy Balance Sheet?
Oct 16Glaukos pays $10M upfront to license iVeena's eye disorder therapy IVMED-80
Aug 24Glaukos: Gross Margins Compressing Despite FY22 Guidance Revision
Aug 04Glaukos gains as Stifel upgrades to Buy citing 2022 sales upside
Jul 12Is Glaukos (NYSE:GKOS) Using Debt Sensibly?
Jun 28Financial Position Analysis
Short Term Liabilities: GKOS's short term assets ($383.8M) exceed its short term liabilities ($70.1M).
Long Term Liabilities: GKOS's short term assets ($383.8M) exceed its long term liabilities ($184.4M).
Debt to Equity History and Analysis
Debt Level: GKOS has more cash than its total debt.
Reducing Debt: GKOS's debt to equity ratio has increased from 0% to 8.5% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: GKOS has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if GKOS has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.